Word

GENEA BIOMEDX GEMS

Status

Registered

Status Code

706

Status Date

Friday, September 8, 2023

Serial Number

79171360

Registration Number

5029077

Registration Date

Tuesday, August 30, 2016

Mark Type

3000

Filing Date

Friday, June 12, 2015

Published for Opposition

Tuesday, June 14, 2016

Trademark Owner History

Genea IP Holdings Pty Ltd - Original Registrant

Classifications

5 Culture media for medical use for use to support growth of human cells, human embryos, human reproductive tissue, human sperm, human blastocysts or human oocytes for medical purposes; cell culture media for medical use for use to support growth of human cells, human embryos, human reproductive tissue, human sperm, human blastocysts or human oocytes for medical purposes; human cell products, namely, pluripotent and differentiated human cells and stem cells for medical or clinical use; cell culture media for use in medical or medical research applications for cultivating human cells, human embryos, human reproductive tissue, human sperm, human blastocysts or human oocytes; biological and chemical products and substances for medical use excluding dietary supplements, nutritional supplements, vaccines and antibiotics, namely, chemicals for medical or clinical use in relation to assisted reproductive therapies, cell fertilisation, cell division and cell cultivation and diagnosing and/or treating fertility and other disorders relating to fertility and reproduction, chemical preparations for medical or clinical use in relation to assisted reproductive therapies, cell fertilisation, cell division and cell cultivation and diagnosing and/or treating fertility and other disorders relating to fertility and human reproduction, chemical preparations for the treatment of infertility and other disorders relating to fertility and human reproduction, biological preparations for the treatment of infertility and other disorders relating to fertility and human reproduction, biological preparations to support growth of human cells, human embryos, human reproductive tissue, human sperm, human blastocysts or human oocytes, chemical preparations to support growth of human cells, human embryos, human reproductive tissue, human sperm, human blastocysts or human oocytes, chemical reagents for medical use in relation to assisted reproductive therapies, cell fertilisation, cell division and cell cultivation and diagnosing and/or treating fertility and other disorders relating to fertility and reproduction; pharmaceutical preparations for the treatment of infertility and other disorders relating to fertility and human reproduction, excluding dietary supplements, nutritional supplements, vaccines and antibiotics

1 Cell culture media other than for medical or veterinary use, namely, for laboratory use in relation to researching, diagnosing and/or treating infertility and other disorders relating to fertility and reproduction and in relation to researching and/or undertaking cell fertilisation, division and cultivation; cell culture media other than for medical or veterinary use, namely, for scientific and research use in relation to researching, diagnosing and/or treating infertility and other disorders relating to fertility and reproduction and in relation to researching and/or undertaking cell fertilisation, division and cultivation; human cell products, namely, pluripotent and differentiated human cells and stem cells for research or scientific purposes; human cell products, namely, pluripotent and differentiated human cells and stem cells for laboratory use excluding medical and veterinary use; biological and chemical products and substances for scientific use other than for medical or veterinary use, namely, chemicals for use in science in relation to researching, diagnosing and/or treating infertility and other disorders relating to fertility and reproduction and in relation to researching and/or undertaking cell fertilisation, division and cultivation, chemical preparations for scientific purposes in relation to researching, diagnosing and/or treating infertility and other disorders relating to fertility and reproduction and in relation to researching and/or undertaking cell fertilisation, division and cultivation, biological preparations to support growth of human cells, human embryos, human reproductive tissue, human sperm, human blastocysts or human oocytes, chemical preparations to support growth of human cells, human embryos, human reproductive tissue, human sperm, human blastocysts or human oocytes, chemical reagents for scientific use in relation to researching, diagnosing and/or treating fertility and other disorders relating to fertility and reproduction and in relation to researching and/or undertaking cell fertilisation, division and cultivation

The mark consists of a square divided by a curved line, next to the stylized wording "GENEA BIOMEDX", which is above the larger stylized wording "GEMS".
Color is not claimed as a feature of the mark.

Trademark Events

Sep 8, 2023

Notice Of Acceptance Of Sec. 71 - E-Mailed

Sep 8, 2023

Registered-Sec.71 Accepted

Sep 7, 2023

Case Assigned To Post Registration Paralegal

Feb 20, 2023

Teas Section 71 Received

Jan 7, 2022

New Representative At Ib Received

Aug 30, 2021

Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed

Feb 15, 2019

New Representative At Ib Received

Jan 18, 2019

Attorney/Dom.Rep.Revoked And/Or Appointed

Jan 18, 2019

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Feb 17, 2017

Final Decision Transaction Processed By Ib

Feb 1, 2017

Final Disposition Notice Sent To Ib

Feb 1, 2017

Final Disposition Processed

Nov 30, 2016

Final Disposition Notice Created, To Be Sent To Ib

Aug 30, 2016

Registered-Principal Register

Jul 22, 2016

Notification Of Possible Opposition - Processed By Ib

Jul 13, 2016

Teas Change Of Correspondence Received

Jun 14, 2016

Published For Opposition

Jun 1, 2016

Notification Of Possible Opposition Sent To Ib

Jun 1, 2016

Notice Of Start Of Opposition Period Created, To Be Sent To Ib

May 25, 2016

Notice Of Publication

May 7, 2016

Approved For Pub - Principal Register

Apr 7, 2016

Teas/Email Correspondence Entered

Apr 7, 2016

Correspondence Received In Law Office

Apr 7, 2016

Teas Response To Office Action Received

Oct 24, 2015

Refusal Processed By Ib

Oct 8, 2015

Non-Final Action Mailed - Refusal Sent To Ib

Oct 8, 2015

Refusal Processed By Mpu

Oct 7, 2015

Non-Final Action (Ib Refusal) Prepared For Review

Oct 6, 2015

Non-Final Action Written

Sep 22, 2015

Assigned To Examiner

Sep 8, 2015

Application Filing Receipt Mailed

Sep 2, 2015

New Application Office Supplied Data Entered

Aug 27, 2015

Sn Assigned For Sect 66a Appl From Ib